Cardioprotection Against Acute Myocardial Infarction 1st ed. 2019 [Kõva köide]

  • Formaat: Hardback, 62 pages, kõrgus x laius: 235x155 mm, 15 Illustrations, color; 7 Illustrations, black and white; X, 62 p. 22 illus., 15 illus. in color., 1 Hardback
  • Ilmumisaeg: 18-Nov-2019
  • Kirjastus: Springer Verlag, Singapore
  • ISBN-10: 9811501653
  • ISBN-13: 9789811501654
Teised raamatud teemal:
  • Kõva köide
  • Hind: 121,97 EUR*
  • Tavahind: 143,49 EUR
  • Säästad 15%
  • Lisa soovinimekirja
  • Lisa ostukorvi
  • Kogus:
  • Tasuta tarne
  • Tellimisaeg 2-4 nädalat
  • See raamat ei ole veel ilmunud. Raamatu kohalejõudmiseks kulub orienteeruvalt 2-4 nädalat peale raamatu väljaandmist.
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Formaat: Hardback, 62 pages, kõrgus x laius: 235x155 mm, 15 Illustrations, color; 7 Illustrations, black and white; X, 62 p. 22 illus., 15 illus. in color., 1 Hardback
  • Ilmumisaeg: 18-Nov-2019
  • Kirjastus: Springer Verlag, Singapore
  • ISBN-10: 9811501653
  • ISBN-13: 9789811501654
Teised raamatud teemal:
This book will provide readers with a detailed understanding of the ischemic damage to the  myocardium after myocardial infarction, as well as essential tools for the treatment of damaged heart after myocardial infarction. It discusses various methods such as pharmacological pre- and post-conditioning, cytokine therapy, and cell therapy especially using Muse cells.The coverage of Muse cell therapy, which includes the latest work done by the author and his collaborators, is a unique feature of the book. Muse cells have self-renewability and have ability to differentiate into cells with the characteristics of all three germ layers from a single cell, while they are non-tumorigenic. It is the first book to feature the Muse cell therapy, which may offer the new promising therapeutic strategy for acute  myocardial infarction. 
Chapter 1: Myocardial infarction and development of heart failure.-
Chapter 2: Ischemic preconditioning.
Chapter 3: Pharmacological preconditioning.
Chapter 4: Ischemic postconditioning.
Chapter 5: Pharmacological postconditioning.
Chapter 6: Cytokine therapy.
Chapter 7: Stem cell therapy.
Chapter 8: Future application and perspectives.
Shinya Minatoguchi, MD, PhD Emeritus Professor, Gifu University Research Professor, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu City, Gifu Prefecture 501-1194, Japan Head of Heart Failure Center, Gifu Municipal Hospital, 7-1 Kashimacho, Gifu City, Gifu Prefecture 500-8513, Japan

Tellige see raamat tutvumiseks meie kauplusesse!Raekoja plats 11, 51004 Tartu

Juhul, kui soovite raamatuga enne ostu tutvuda, siis palun sisestaga allpool oma nimi ning e-mail.
Võimaluse korral tellime raamatu poodi ning teavitame ka teid, kui raamat on müügile jõudnud.

* - väljad on kohustuslikud